Product Details for ANDA 075731
CLORAZEPATE DIPOTASSIUM (CLORAZEPATE DIPOTASSIUM)
3.75MG
Marketing Status: Prescription
7.5MG
Marketing Status: Prescription
15MG
Marketing Status: Prescription
3.75MG
Marketing Status: Prescription
Active Ingredient: CLORAZEPATE DIPOTASSIUM
Proprietary Name: CLORAZEPATE DIPOTASSIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 3.75MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A075731
Product Number: 003
Approval Date: Apr 27, 2000
Applicant Holder Full Name: TARO PHARMACEUTICAL INDUSTRIES LTD
Marketing Status: Prescription
Patent and Exclusivity Information
CLORAZEPATE DIPOTASSIUM (CLORAZEPATE DIPOTASSIUM)
Proprietary Name: CLORAZEPATE DIPOTASSIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 3.75MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A075731
Product Number: 003
Approval Date: Apr 27, 2000
Applicant Holder Full Name: TARO PHARMACEUTICAL INDUSTRIES LTD
Marketing Status: Prescription
Patent and Exclusivity Information
7.5MG
Marketing Status: Prescription
Active Ingredient: CLORAZEPATE DIPOTASSIUM
Proprietary Name: CLORAZEPATE DIPOTASSIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 7.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A075731
Product Number: 002
Approval Date: Apr 27, 2000
Applicant Holder Full Name: TARO PHARMACEUTICAL INDUSTRIES LTD
Marketing Status: Prescription
Patent and Exclusivity Information
CLORAZEPATE DIPOTASSIUM (CLORAZEPATE DIPOTASSIUM)
Proprietary Name: CLORAZEPATE DIPOTASSIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 7.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A075731
Product Number: 002
Approval Date: Apr 27, 2000
Applicant Holder Full Name: TARO PHARMACEUTICAL INDUSTRIES LTD
Marketing Status: Prescription
Patent and Exclusivity Information
15MG
Marketing Status: Prescription
Active Ingredient: CLORAZEPATE DIPOTASSIUM
Proprietary Name: CLORAZEPATE DIPOTASSIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 15MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A075731
Product Number: 001
Approval Date: Apr 27, 2000
Applicant Holder Full Name: TARO PHARMACEUTICAL INDUSTRIES LTD
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: CLORAZEPATE DIPOTASSIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 15MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A075731
Product Number: 001
Approval Date: Apr 27, 2000
Applicant Holder Full Name: TARO PHARMACEUTICAL INDUSTRIES LTD
Marketing Status: Prescription
Patent and Exclusivity Information